Range Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Buy
13,678
+441
+3% +$11.5K 0.09% 174
2026
Q1
$372K Buy
13,237
+199
+2% +$5.3K 0.12% 155
2025
Q4
$325K Sell
13,038
-4,274
-25% -$108K 0.11% 169
2025
Q3
$441K Buy
17,312
+368
+2% +$9.08K 0.16% 143
2025
Q2
$411K Sell
16,944
-729
-4% -$17K 0.16% 145
2025
Q1
$448K Buy
17,673
+4,356
+33% +$114K 0.2% 119
2024
Q4
$353K Buy
+13,317
New +$361K 0.16% 137
2024
Q3
Sell
-13,861
Closed -$388K 155
2024
Q2
$388K Buy
13,861
+314
+2% +$8.64K 0.2% 122
2024
Q1
$376K Buy
13,547
+5,672
+72% +$157K 0.2% 128
2023
Q4
$227K Sell
7,875
-2,989
-28% -$90.4K 0.14% 149
2023
Q3
$360K Sell
10,864
-340
-3% -$12K 0.24% 119
2023
Q2
$411K Sell
11,204
-25,806
-70% -$1M 0.26% 120
2023
Q1
$1.51M Buy
37,010
+1,024
+3% +$44.2K 0.99% 24
2022
Q4
$1.84M Buy
35,986
+666
+2% +$31.9K 1.26% 13
2022
Q3
$1.55M Buy
35,320
+156
+0.4% +$7.58K 1.19% 16
2022
Q2
$1.84M Sell
35,164
-10,106
-22% -$515K 1.34% 9
2022
Q1
$2.34M Buy
45,270
+10,682
+31% +$554K 1.5% 7
2021
Q4
$2.04M Buy
34,588
+80
+0.2% +$3.96K 1.35% 14
2021
Q3
$1.48M Buy
34,508
+778
+2% +$34.5K 1.07% 25
2021
Q2
$1.32M Buy
33,730
+3,250
+11% +$126K 0.98% 33
2021
Q1
$1.1M Buy
+30,480
New +$1.08M 1% 34

Other funds holding PFE

Range Financial Group's PFE Position: Q2 2026 in Review

Range Financial Group increased its Pfizer (PFE) stake by 3.3% in Q2 2026, buying an estimated $11.5K and bringing the position to 13,678 shares worth $329K. The position accounts for 0.09% of the portfolio, ranked #174.

Range Financial Group first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.34M in Q1 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Range Financial Group held 13,678 shares of Pfizer worth $329K as of Q2 2026.
  • Range Financial Group bought 441 Pfizer shares in Q2 2026, an estimated $11.5K.
  • Pfizer made up 0.09% of Range Financial Group's portfolio in Q2 2026, its #174 holding.
  • Range Financial Group first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
  • Range Financial Group's Pfizer position peaked at $2.34M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.